hVIVO | Sustainability Performance
Engaged in the clinical research and development sector, focusing on human challenge studies and viral infections. The company aims to support the pharmaceutical industry in developing vaccines and antiviral therapies through innovative clinical trial solutions.
2011
United Kingdom
201 - 500 employees
Biotechnology
$25M - 100M in revenue
$10M - 25M in profitability
Sustainability Ranking & Industry Benchmark
#5287
Overall#764
in United Kingdom#84
in BiotechnologySustainability Maturity
Sustainability Intent
Overview
Environmental
Digital emissions
Digital Emissions
CO2e per visit (g)
Industry benchmark
B/M 0.26 g
D
Environmental ScoreScore D
Green HostingYes
Controversy level
- hVIVO's human challenge trial model intentionally infects healthy volunteers with pathogens, raising bioethics considerations.
